Filing Details
- Accession Number:
- 0001807094-20-000031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-28 19:21:18
- Reporting Period:
- 2020-12-22
- Accepted Time:
- 2020-12-28 19:21:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1175680 | Cytodyn Inc. | CYDY | Pharmaceutical Preparations (2834) | 753056237 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1257911 | D. Michael Mulholland | 1111 Main Street, Suite 660 Vancouver WA 98660 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-22 | 161,801 | $0.87 | 445,882 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-12-22 | 150,000 | $0.90 | 595,882 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-12-22 | 300,000 | $1.09 | 895,882 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-12-22 | 100,000 | $1.40 | 995,882 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-22 | 245,704 | $5.49 | 750,178 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-22 | 453,997 | $6.61 | 296,181 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-22 | 12,100 | $7.00 | 284,081 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (right to buy) | Acquisiton | 2020-12-22 | 161,801 | $0.00 | 161,801 | $0.87 |
| Common Stock | Non-qualified Stock Option (right to buy) | Acquisiton | 2020-12-22 | 150,000 | $0.00 | 150,000 | $0.90 |
| Common Stock | Non-qualified Stock Option (right to buy) | Acquisiton | 2020-12-22 | 300,000 | $0.00 | 300,000 | $1.09 |
| Common Stock | Non-qualified Stock Option (right to buy) | Acquisiton | 2020-12-22 | 100,000 | $0.00 | 100,000 | $1.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-12-22 | 2025-11-23 | No | 4 | M | Direct |
| 0 | 2020-12-22 | 2025-06-30 | No | 4 | M | Direct |
| 0 | 2020-12-22 | 2026-06-01 | No | 4 | M | Direct |
| 0 | 2020-12-22 | 2022-12-13 | No | 4 | M | Direct |
Footnotes
- The sale transactions reported in this Form 4 were made pursuant to a Rule 10b5-1 trading plan the Reporting Person entered into on November 12, 2020. The plan provides for the periodic sales by the Reporting Person's broker without further action by the Reporting Person.
- This transaction was executed in multiple trades at prices ranging from $5.03 to $5.98. The price above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $6.02 to $6.99. The price above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
